EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection

Seyed Alireza Mousavi Kahaki iD, Nayereh Ebrahimzadeh, Hossein Fahimi iD, Arfa Moshiri

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310368 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Seyed Alireza Mousavi Kahaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Advanced Science and Technology, Department of Genetics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Knockout Techniques, Transfection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clustered regularly interspaced short palindromic repeats (CRISPR) system offers cost-effectiveness, high efficiency, precision, and ease of use compared to traditional gene editing techniques. In this study, we employed findings from prestigious investigations to develop an optimized approach for generating knockout cancer cell lines using a transient transfection method. This protocol introduces a distinctive approach that follows rigorous guidelines for designing gRNA to reduce off-target effects, a major challenge in CRISPR applications. Our step-by-step instructions allow researchers, particularly those with limited laboratory equipment and funding, as well as those undertaking CRISPR projects for the first time, to generate knockout cell lines using CRISPR technology in just ten weeks. This protocol covers all needs for enhancing various yields, such as transfection efficiency, and includes leveraging robust bioinformatics tools, conducting essential assays, isolating monoclonal cells via limiting dilution, validating knockout cells, and providing comprehensive troubleshooting recommendations. Using this method, we successfully created several new generations of colorectal cancer cell lines with monoallelic and biallelic knockouts of the epithelial cell adhesion molecule (EpCAM) gene. Our method, optimized for a wide spectrum of cancer cell lines, makes CRISPR more accessible for applications in personalized and precision medicine. It expands opportunities for novel investigations into cancer mechanisms and paves the way for potential therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene Knockout TechniquesTransfectionHumansCell Line, TumorEpithelial Cell Adhesion MoleculeRNA, Guide, CRISPR-Cas SystemsGene EditingColorectal Neoplasms

Substanzen

Epithelial Cell Adhesion MoleculeRNA, Guide, CRISPR-Cas SystemsEPCAM protein, human

Autor:innen und Institutionen

  • Faculty of Advanced Science and Technology, Department of Genetics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Microbiology Research Center, Tehran, Iran.

ORCID-Profile: Seyed Alireza Mousavi Kahaki, Hossein Fahimi

Zitieren

APA

Mousavi Kahaki, S. A., Ebrahimzadeh, N., Fahimi, H., & Moshiri, A. (2024). Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection. PLOS ONE. https://doi.org/10.1371/journal.pone.0310368

Vancouver

Mousavi Kahaki SA, Ebrahimzadeh N, Fahimi H, Moshiri A. Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection. PLOS ONE. 2024. doi:10.1371/journal.pone.0310368

BibTeX
@article{MousaviKahaki2024,
  author = {Mousavi Kahaki, Seyed Alireza and Ebrahimzadeh, Nayereh and Fahimi, Hossein and Moshiri, Arfa},
  title = {Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310368}
}
Kostenlos starten →